Head-to-head comparison
NuBloom vs Peter MD
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
NuBloom is a women's metabolic-health telehealth practice founded by family and integrative-medicine physician Dr.
From $149/mo (lowest dose rung) sema · From $279/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Compounding pharmacy partners are not named anywhere on the site — a transparency gap
Desk Score
A physician-prescribed telehealth brand pairing GLP-1 tirzepatide and compounded semaglutide+B12 with TRT, sermorelin, NAD+, hair-loss and ED care on one account — tirzepatide from $249/mo, semaglutide+B12 from $149/mo.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Verified August 2026
Marked down on: Tirzepatide steps up after month one — $149 for the first month, then $249/mo billed quarterly
Peter MD takes this head-to-head with the higher Desk Score, 77/100 (C+) against 66/100 (C) for NuBloom. NuBloom still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
NuBloom
66/100
C
Peter MD
77/100
C+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | NuBloom | Peter MD |
|---|---|---|
| Semaglutide | From $149/molowest dose rung$149/mo (2.4 mg dose, compounded) | $149/mofirst month only$149/mo (GLP1+B12, compounded, first-time tier; $139/mo returning-patient tier) |
| Tirzepatide | From $279/molowest dose rung$279/mo (15 mg dose, compounded) | $249/moquarterly prepay$249/mo (60mg, billed quarterly; $149 first month) |
| Coverage | 49 states | Most states (restrictions vary by treatment — excludes several, incl. AL, ID) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching. | Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes. |
| Desk Score | 66/100C | 77/100C+ |
The verdict
Desk pick — Peter MDPeter MD takes this head-to-head with the higher Desk Score, 77/100 (C+) against 66/100 (C) for NuBloom. NuBloom still holds its ground where its strengths line up with yours.
Choose NuBloom if…
Women seeking a physician-founded, whole-person GLP-1 and hormone program with optional 1:1 coaching.
From $149/mo (lowest dose rung) sema · From $279/mo (lowest dose rung) tirz · 49 states
Choose Peter MD if…
Patients who want GLP-1 care alongside TRT, NAD+, sermorelin or other men's-health treatments under one physician-guided account, and don't need brand-name or oral routes.
$149/mo (first month only) sema · $249/mo (quarterly prepay) tirz · Most states (restrictions vary by treatment — excludes several, incl. AL, ID)
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: NuBloom · Peter MD.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs NuBloom
- CoreAge Rx vs Peter MD
- NuBloom vs Ondra Health
- Ondra Health vs Peter MD
- NuBloom vs Tyde Wellness
- Peter MD vs Tyde Wellness
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.